Everlum Bio
Everlume Bio is a biotechnology company focused on curing rare diseases through a personalized approach to medicine. They utilize a proprietary AI platform and collaborate with leading scientists to create customized therapeutics, including gene therapies and small molecules. Their innovative Cure Plan accelerates drug discovery and development, allowing for rapid proof of concept and FDA approval processes. With over 100 potential therapeutics developed and 17 progressing to clinical trials, Everlume is positioned to make significant impacts in the rare disease market, aiming to eliminate rare diseases by 2035.
Everlum Bio
Everlume Bio is a biotechnology company focused on curing rare diseases through a personalized approach to medicine. They utilize a proprietary AI platform and collaborate with leading scientists to create customized therapeutics, including gene therapies and small molecules. Their innovative Cure Plan accelerates drug discovery and development, allowing for rapid proof of concept and FDA approval processes. With over 100 potential therapeutics developed and 17 progressing to clinical trials, Everlume is positioned to make significant impacts in the rare disease market, aiming to eliminate rare diseases by 2035.